genedrive plc (LON:GDR)
1.33p+2.31%
Spriggl Score: Weak— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“NHS commissioning progress offers clinical promise; extreme share dilution and cash burn threaten total value loss.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About genedrive plc
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocy…
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- £19.3M
Recent dividends
No recent dividends recorded.
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across genedrive plc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free